WiLAN Subsidiary Acquires Medical Patent Portfolio

OTTAWA, Canada – June 10, 2014 – Wi-LAN Inc. (“WiLAN” or the “Company”) (TSX:WIN) (NASD:WILN) today announced that a subsidiary has acquired a portfolio of medical patents that relate to Stent technology.

"With the acquisition of this medical technology, and a strong opportunity pipeline, WiLAN is seeing significant demand from inventors and small companies, in diverse markets, looking to monetize their valuable inventions,” said Jim Skippen, President & CEO. “The acquired technology helps address vascular blood flow complications.”

The acquisition of this portfolio will be funded through an upfront payment and the sharing of net revenues generated by licensing the patents. WiLAN can confirm that it does not consider the upfront payment amount to be material relative to its current cash position. All other terms of the agreement are confidential.